Stammdaten
Unternehmen
| Name | Nurix Therapeutics, Inc. |
|---|---|
| Ticker | NRIX |
| CIK | 0001549595 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Nurix Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-22 13:18:44.049369 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-11-30 | 10-K | 83,980,000 | -264,457,000 | -3.05 | 688,135,000 | 538,747,000 |
| 2023-11-30 | 10-K | 76,987,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -8,148 | 15.44 | -125,792.90 | -154,5% | |
| 2026-03-02 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -8,148 | 15.44 | -125,792.90 | -154,5% | |
| 2026-02-09 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -14,261 | 16.66 | -237,618.21 | -291,8% | |
| 2026-02-09 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -14,261 | 16.66 | -237,618.21 | -291,8% | |
| 2026-01-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -73 | 17.37 | -1,268.13 | -1,6% | |
| 2026-01-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -73 | 17.37 | -1,268.13 | -1,6% | |
| 2026-01-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -4,333 | 16.58 | -71,852.41 | -88,2% | |
| 2026-01-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -88 | 17.37 | -1,528.71 | -1,9% | |
| 2026-01-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -4,333 | 16.58 | -71,852.41 | -88,2% | |
| 2026-01-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -88 | 17.37 | -1,528.71 | -1,9% | |
| 2026-01-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -4,797 | 16.58 | -79,546.73 | -97,7% | |
| 2026-01-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -98 | 17.37 | -1,702.43 | -2,1% | |
| 2026-01-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -4,797 | 16.58 | -79,546.73 | -97,7% | |
| 2026-01-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -98 | 17.37 | -1,702.43 | -2,1% | |
| 2026-01-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -3,588 | 16.58 | -59,498.37 | -73,1% | |
| 2026-01-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -3,588 | 16.58 | -59,498.37 | -73,1% | |
| 2026-01-20 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,760 | 18.42 | -69,273.11 | -85,1% | |
| 2026-01-20 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,760 | 18.42 | -69,273.11 | -85,1% | |
| 2025-12-18 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,560 | 17.87 | -63,603.32 | -78,1% | |
| 2025-12-18 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -200 | 18.56 | -3,711.00 | -4,6% | |
| 2025-12-18 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,560 | 17.87 | -63,603.32 | -78,1% | |
| 2025-12-18 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -200 | 18.56 | -3,711.00 | -4,6% | |
| 2025-11-24 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -37,600 | 17.07 | -641,696.64 | -787,9% | |
| 2025-11-24 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -37,600 | 17.07 | -641,696.64 | -787,9% | |
| 2025-11-03 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -6,284 | 12.56 | -78,931.44 | -96,9% | |
| 2025-11-03 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -6,284 | 12.56 | -78,931.44 | -96,9% | |
| 2025-10-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,644 | 12.80 | -46,631.17 | -57,3% | |
| 2025-10-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,644 | 12.80 | -46,631.17 | -57,3% | |
| 2025-10-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -4,087 | 12.80 | -52,300.11 | -64,2% | |
| 2025-10-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -4,087 | 12.80 | -52,300.11 | -64,2% | |
| 2025-10-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -3,130 | 12.80 | -40,053.67 | -49,2% | |
| 2025-10-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -3,130 | 12.80 | -40,053.67 | -49,2% | |
| 2025-08-01 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -5,402 | 11.03 | -59,597.57 | -73,2% | |
| 2025-08-01 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -5,402 | 11.03 | -59,597.57 | -73,2% | |
| 2025-07-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -4,308 | 12.01 | -51,743.39 | -63,5% | |
| 2025-07-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,841 | 12.01 | -46,134.25 | -56,6% | |
| 2025-07-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -3,841 | 12.01 | -46,134.25 | -56,6% | |
| 2025-07-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -4,304 | 12.01 | -51,695.34 | -63,5% | |
| 2025-07-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -4,304 | 12.01 | -51,695.34 | -63,5% | |
| 2025-07-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -4,308 | 12.01 | -51,743.39 | -63,5% | |
| 2025-05-02 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -6,198 | 11.33 | -70,242.55 | -86,2% | |
| 2025-05-02 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -6,198 | 11.33 | -70,242.55 | -86,2% | |
| 2025-04-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -2,894 | 11.50 | -33,285.92 | -40,9% | |
| 2025-04-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -3,377 | 11.50 | -38,841.24 | -47,7% | |
| 2025-04-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -2,438 | 11.50 | -28,041.14 | -34,4% | |
| 2025-04-30 | Ring Christine | Officer, Chief Legal Officer | Open Market Sale | -2,894 | 11.50 | -33,285.92 | -40,9% | |
| 2025-04-30 | van Houte Hans | Officer, Chief Financial Officer | Open Market Sale | -2,438 | 11.50 | -28,041.14 | -34,4% | |
| 2025-04-30 | Hansen Gwenn | Officer, Chief Scientific Officer | Open Market Sale | -3,377 | 11.50 | -38,841.24 | -47,7% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.